[Parietal abdominal hematoma after combined acenocoumarol and roxithromycin treatment].
Chassany
O
O
Logeart
I
I
Choulika
S
S
Caulin
C
C
D015110:4-Hydroxycoumarins; D000005:Abdomen; D000074:Acenocoumarol / Q000009:adverse effects*; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000925:Anticoagulants / Q000009:adverse effects*; D003327:Coronary Disease / Q000188:drug therapy; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004347:Drug Interactions; D006406:Hematoma / Q000139:chemically induced*; D006801:Humans; D007192:Indenes; D008099:Liver / Q000201:enzymology; D008297:Male; D015575:Roxithromycin / Q000009:adverse effects*; D014812:Vitamin K / Q000037:antagonists & inhibitors
D015110:4-Hydroxycoumarins; D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D007192:Indenes; C011664:antivitamins K; D014812:Vitamin K; D015575:Roxithromycin; D003577:Cytochrome P-450 Enzyme System; D000074:Acenocoumarol
Hématome pariétal abdominal lors d'un traitement associant acénocoumarol et roxithromycine.